Table 1 Baseline characteristics of diabetic and non-diabetic patients
Parameter | Diabetic (430) | Non-diabetic (1200) | p-value |
|---|---|---|---|
Physical characteristics | |||
 Female sex (%) | 82 (19.1) | 292 (24.3) | 0.031 |
 Age (years) | 72.6 ± 5.5 | 73.0 ± 5.4 | 0.274 |
 BMI (kg/m2) | 28.6 ± 4.1 | 26.6 ± 4.0 | 0.0000 |
 Waist circumference (cm) | 104.2 ± 11.4 | 98.5 ± 11.2 | 0.0000 |
 Skinfold thickness (mm) | 64.3 ± 23.2 | 58.7 ± 20.2 | 0.0000 |
 Body fat (%) | 30.5 ± 6.4 | 29.5 ± 6.2 | 0.007 |
Educational attainment | 0.0001 | ||
 Primary education | 145 (34.0%) | 314 (26.3%) |  |
 Secondary education | 209 (49.1%) | 579 (47.4%) |  |
 Tertiary education | 72 (16.9%) | 313 (26.3%) |  |
Index intervention | 0.003 | ||
 VHD | 37 (8.6%) | 129 (10.8%) |  |
 CABG | 136 (31.6%) | 344 (28.7%) |  |
 PCI | 218 (50.7%) | 670 (55.8%) |  |
 Stable angina | 39 (9.1%) | 57 (4.8%) |  |
Cardiovascular risk factors | |||
 Smoking (active/former/never) | 44/76/309 | 110/193/897 | 0.543 |
 Days with > 30 min physical activity | 3.3 ± 2.8 | 4.0 ± 2.7 | 0.0000 |
 Previous ACS | 104 (24.3%) | 200 (16.7%) | 0.0007 |
Comorbidities | |||
 Hypertension | 333 (77.4%) | 775 (64.6%) | 0.0000 |
 Hypercholesteremia | 326 (76.0%) | 770 (64.2%) | 0.0000 |
 Family history of CVD | 111 (26.0%) | 383 (32.0%) | 0.024 |
 Nephropathy | 57 (13.3%) | 67 (5.6%) | 0.0000 |
 Chronic heart failure | 16 (3.7%) | 26 (2.2%) | 0.115 |
 Peripheral arterial disease | 57 (13.3%) | 68 (5.7%) | 0.0000 |
 Obstructive sleep apnea | 19 (4.4%) | 24 (2.0%) | 0.012 |
 Anaemia | 200 (57.0%)* | 484 (49.4%)* | 0.018 |
 Atrial fibrillation | 34 (7.9%) | 79 (6.6%) | 0.408 |
 LV ejection fraction < 35% | 19 (4.4%) | 46 (3.9%) | 0.290 |
Medication | |||
 Insulin | 114 (26.5%) |  |  |
 Oral antidiabetics | 253 (58.8%) |  |  |
 Beta blocker | 359 (83.5%) | 965 (80.4%) | 0.184 |
 Statins | 394 (91.6%) | 1063 (88.6%) | 0.095 |
 ACE inhibitors | 198 (46.0%) | 609 (50.8%) | 0.103 |
 ARBs | 110 (25.6%) | 198 (16.5%) | 0.0000 |